Literature DB >> 10971742

Immunopathology of in situ seminoma.

B Bols1, L Jensen, A Jensen, O Braendstrup.   

Abstract

In this study of the seminomatous human testis the composition, activity and apoptosis of lymphocytes infiltrating the immune-privileged seminiferous tubules with in situ seminoma were studied by immunohistochemistry and DNA fragmentation detection. Likewise the lymphocytes infiltrating the invasive seminomas were studied. The study showed equal numbers of CD4+ and CD8+ T cells and B cells, about 30% of the cells. Very few T gamma/delta and NK cells were present. The activity in terms of IL-2-R, FasL and perforin expression was low. Apoptosis of the lymphocytic cells was limited. No differences were observed between the lymphocytes in seminiferous tubules with in situ seminoma and the lymphocytes in invasive tumours. The study suggests that either specifically committed lymphocytes are not present or, if present, immune-suppressing mechanisms in addition to FasL may be working.

Entities:  

Mesh:

Year:  2000        PMID: 10971742      PMCID: PMC2517725          DOI: 10.1046/j.1365-2613.2000.00151.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  29 in total

1.  In situ observation of inflammatory cell-tumor cell interaction in human seminomas (germinomas): light, electron microscopic, and immunohistochemical study.

Authors:  Y Q Wei; Z B Hang; K F Liu
Journal:  Hum Pathol       Date:  1992-04       Impact factor: 3.466

Review 2.  Antigen recognition by class I-restricted T lymphocytes.

Authors:  A Townsend; H Bodmer
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 3.  Perspectives on the role of MHC antigens in normal and malignant cell development.

Authors:  B E Elliott; D A Carlow; A M Rodricks; A Wade
Journal:  Adv Cancer Res       Date:  1989       Impact factor: 6.242

4.  Immune and non-immune control of neoplastic development: contrasting effects of host and tumor evolution.

Authors:  G Klein
Journal:  Cancer       Date:  1980-05-15       Impact factor: 6.860

5.  Fas and Fas-ligand expression in seminomatous testes.

Authors:  O Braendstrup; B Bols; L Jensen
Journal:  APMIS       Date:  1999-04       Impact factor: 3.205

6.  Immunohistochemical characterization of seminoma and its inflammatory cell infiltrate.

Authors:  D A Bell; T J Flotte; A K Bhan
Journal:  Hum Pathol       Date:  1987-05       Impact factor: 3.466

7.  Immunohistological analysis of tumour infiltrating lymphocytes in seminoma using monoclonal antibodies.

Authors:  T Nakanoma; K Nakamura; N Deguchi; J Fujimoto; H Tazaki; J Hata
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

8.  Analysis of the autoimmune response in an 'in situ' carcinoma of the testis.

Authors:  D Lehmann; H Müller
Journal:  Int J Androl       Date:  1987-02

9.  Immunological paradox in testicular tumours: the presence of a large number of activated T-cells despite the complete absence of MHC antigens.

Authors:  A M Nouri; R F Hussain; R T Oliver; A M Handy; I Bartkova; J G Bodmer
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

10.  Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro.

Authors:  F Vánky; P Wang; M Patarroyo; E Klein
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

View more
  7 in total

Review 1.  Microinvasive germ cell tumor of the testis.

Authors:  Finn Edler von Eyben; Grete Krag Jacobsen; Rolf Inge Skotheim
Journal:  Virchows Arch       Date:  2005-06-21       Impact factor: 4.064

Review 2.  The Good, the Bad and the Ugly of Testicular Immune Regulation: A Delicate Balance Between Immune Function and Immune Privilege.

Authors:  Gurvinder Kaur; Kandis Wright; Saguna Verma; Allan Haynes; Jannette M Dufour
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Spontaneous CD4+ and CD8+ T-cell responses directed against cancer testis antigens are present in the peripheral blood of testicular cancer patients.

Authors:  Hayden Pearce; Paul Hutton; Shalini Chaudhri; Emilio Porfiri; Prashant Patel; Richard Viney; Paul Moss
Journal:  Eur J Immunol       Date:  2017-06-26       Impact factor: 5.532

4.  Emerging Prognostic Biomarkers in Testicular Germ Cell Tumors: Looking Beyond Established Practice.

Authors:  Michal Chovanec; Costantine Albany; Michal Mego; Rodolfo Montironi; Alessia Cimadamore; Liang Cheng
Journal:  Front Oncol       Date:  2018-11-28       Impact factor: 6.244

5.  Targeting EpCAM by a Bispecific Trifunctional Antibody Exerts Profound Cytotoxic Efficacy in Germ Cell Tumor Cell Lines.

Authors:  Stefan Schönberger; Daniela Kraft; Daniel Nettersheim; Hubert Schorle; Anna Casati; Rogerio B Craveiro; Mahsa Mir Mohseni; Gabriele Calaminus; Dagmar Dilloo
Journal:  Cancers (Basel)       Date:  2020-05-19       Impact factor: 6.639

Review 6.  Immune-Related Concepts in Biology and Treatment of Germ-Cell Tumors.

Authors:  Michal Chovanec; Ugo De Giorgi; Michal Mego
Journal:  Adv Urol       Date:  2018-03-13

Review 7.  Infectious, inflammatory and 'autoimmune' male factor infertility: how do rodent models inform clinical practice?

Authors:  Monika Fijak; Adrian Pilatz; Mark P Hedger; Nour Nicolas; Sudhanshu Bhushan; Vera Michel; Kenneth S K Tung; Hans-Christian Schuppe; Andreas Meinhardt
Journal:  Hum Reprod Update       Date:  2018-07-01       Impact factor: 15.610

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.